Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11795 | 890 | 33.9 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
580 | 13536 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DNA MULTIPLOIDY | Author keyword | 11 | 100% | 1% | 6 |
2 | DNA PLOIDY | Author keyword | 10 | 10% | 10% | 92 |
3 | DNA PLOIDY HETEROGENEITY | Author keyword | 4 | 75% | 0% | 3 |
4 | CRYPT ISOLATION TECHNIQUE | Author keyword | 3 | 50% | 0% | 4 |
5 | LUNDBERG CANC SURG METAB | Address | 2 | 67% | 0% | 2 |
6 | SECT ONCOBIOL | Address | 2 | 67% | 0% | 2 |
7 | SICILIAN REG | Address | 2 | 67% | 0% | 2 |
8 | DNA PLOIDY PATTERN | Author keyword | 2 | 22% | 1% | 8 |
9 | DNA INDEX | Author keyword | 2 | 12% | 2% | 15 |
10 | DNA ANEUPLOIDY | Author keyword | 2 | 15% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DNA MULTIPLOIDY | 11 | 100% | 1% | 6 | Search DNA+MULTIPLOIDY | Search DNA+MULTIPLOIDY |
2 | DNA PLOIDY | 10 | 10% | 10% | 92 | Search DNA+PLOIDY | Search DNA+PLOIDY |
3 | DNA PLOIDY HETEROGENEITY | 4 | 75% | 0% | 3 | Search DNA+PLOIDY+HETEROGENEITY | Search DNA+PLOIDY+HETEROGENEITY |
4 | CRYPT ISOLATION TECHNIQUE | 3 | 50% | 0% | 4 | Search CRYPT+ISOLATION+TECHNIQUE | Search CRYPT+ISOLATION+TECHNIQUE |
5 | DNA PLOIDY PATTERN | 2 | 22% | 1% | 8 | Search DNA+PLOIDY+PATTERN | Search DNA+PLOIDY+PATTERN |
6 | DNA INDEX | 2 | 12% | 2% | 15 | Search DNA+INDEX | Search DNA+INDEX |
7 | DNA ANEUPLOIDY | 2 | 15% | 1% | 11 | Search DNA+ANEUPLOIDY | Search DNA+ANEUPLOIDY |
8 | DNA HETEROGENEITY | 1 | 25% | 1% | 5 | Search DNA+HETEROGENEITY | Search DNA+HETEROGENEITY |
9 | MONOCLONAL ANTIBODY KI 67 | 1 | 38% | 0% | 3 | Search MONOCLONAL+ANTIBODY+KI+67 | Search MONOCLONAL+ANTIBODY+KI+67 |
10 | COLORECTAL ADENOMAS AND CARCINOMAS | 1 | 100% | 0% | 2 | Search COLORECTAL+ADENOMAS+AND+CARCINOMAS | Search COLORECTAL+ADENOMAS+AND+CARCINOMAS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LARGE BOWEL CARCINOMA | 36 | 71% | 3% | 29 |
2 | COLONIC ADENOCARCINOMAS | 15 | 59% | 2% | 17 |
3 | PLOIDY PATTERNS | 11 | 78% | 1% | 7 |
4 | FLOW CYTOMETRIC DNA | 8 | 27% | 3% | 25 |
5 | HISTOLOGICAL MATERIAL | 7 | 67% | 1% | 6 |
6 | RECTAL ADENOCARCINOMAS | 4 | 75% | 0% | 3 |
7 | TUMOR DNA CONTENT | 4 | 75% | 0% | 3 |
8 | TUMOR SITE | 4 | 27% | 1% | 12 |
9 | DUKES STAGE | 4 | 46% | 1% | 6 |
10 | HISTOPATHOLOGIC DIFFERENTIATION | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis | 2008 | 139 | 140 | 73% |
TP53 mutation in colorectal cancer | 2003 | 123 | 52 | 58% |
Tumour markers of prognosis in colorectal cancer | 1999 | 144 | 97 | 27% |
Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers | 2012 | 6 | 98 | 41% |
Evaluation of heterogeneity of DNA ploidy in early gastric cancers | 1999 | 9 | 19 | 84% |
Is there a case for routine clinical application of ploidy measurements in gastrointestinal tumours? | 2004 | 7 | 237 | 69% |
Systematic review of genetic influences on the prognosis of colorectal cancer | 2004 | 56 | 163 | 26% |
Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature | 2004 | 52 | 141 | 24% |
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? | 2003 | 95 | 130 | 13% |
Significance of cell proliferation measurement in gastric cancer | 1998 | 28 | 61 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUNDBERG CANC SURG METAB | 2 | 67% | 0.2% | 2 |
2 | SECT ONCOBIOL | 2 | 67% | 0.2% | 2 |
3 | SICILIAN REG | 2 | 67% | 0.2% | 2 |
4 | BIOPHYS CYTOMETRY | 1 | 31% | 0.4% | 4 |
5 | UNIT MED EXPT ONCOL | 1 | 50% | 0.2% | 2 |
6 | REG REFERENCE BIOMOL CHARACTERIZAT NEOPLASMS | 1 | 33% | 0.3% | 3 |
7 | ANAT SURG ONCOL | 1 | 50% | 0.1% | 1 |
8 | BIOFIS CITOMETRIA | 1 | 50% | 0.1% | 1 |
9 | COLON RECTAL GEN SURG | 1 | 50% | 0.1% | 1 |
10 | CSTA MUTAGENESIS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000239399 | INTER SIMPLE SEQUENCE REPEAT PCR//BIOPHYS CYTOMETRY//HOSP UNIV SALAMANCA IBSAL |
2 | 0.0000224580 | S PHASE FRACTION//ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//DNA PLOIDY |
3 | 0.0000160897 | HUMAN CYTOGENET TOXICOL GENET//C KI RAS ONCOGENE//JOAO BARROS BARRETO UNIV HOSP |
4 | 0.0000134211 | FLAT ADENOMA//DEPRESSED ADENOMA//POLYPOID GROWTH |
5 | 0.0000117604 | PCNA//PROLIFERATING CELL NUCLEAR ANTIGEN//PKI 67 |
6 | 0.0000083484 | OCCULT NEOPLASTIC CELLS//COMPLETE MESOCOLIC EXCISION//LYMPH NODE YIELD |
7 | 0.0000078856 | PROXIMAL SHIFT//SUBSITE//ANATOMIC SUBSITE |
8 | 0.0000073943 | P53 GENE//P53 MUTANTS//MUTANT P53 |
9 | 0.0000072631 | GEL FIBERGLASS//TERATOL EXPT ONCOL//RAT COLON CANCER |
10 | 0.0000071905 | PANITUMUMAB//CETUXIMAB//METASTATIC COLORECTAL CANCER |